2024 annual financial data
Evommune, Inc. 2024 Operating margin
Evommune, Inc. 2024 operating margin with verified reported values.
Direct answer
Operating margin was -1,000.19%.
Operating income was -70,013,000 USD and net income was -66,808,000 USD.
Operating cash flow was -58,195,000 USD.
Get free Evommune, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,000,000 USD
- Operating income
- -70,013,000 USD
- Net income
- -66,808,000 USD
- Operating cash flow
- -58,195,000 USD